LAMEA Sepsis Diagnostics Market Size, Forecast by 2022-2028

LAMEA Sepsis Diagnostics Market Size, Share & Industry Trends Analysis Report By Method, By Test Type, By Pathogen, By Product, By End-User, By Technology, By Country and Growth Forecast, 2022 - 2028

Published Date: May-2022 | Number of Pages: 142 | Format: PDF | Report ID: KBV-17908

Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support


COVID-19

Get in-depth analysis of the COVID-19 impact on the LAMEA Sepsis Diagnostics Market

Market Report Description

The Latin America, Middle East and Africa Sepsis Diagnostics Market would witness market growth of 14.0% CAGR during the forecast period (2022-2028).

Children account for a significant proportion of the total instances of sepsis diagnosed each year, leading to a considerable number of deaths annually, the majority of which might be avoided with early identification and adequate clinical therapy. Diarrheal illnesses or respiratory illnesses are frequently the cause of these deaths. Obstetric infections, such as infections after an abortion or infections after a caesarean section, are the third leading cause of maternal death.

Biosensors that monitor biological or chemical interactions are frequently used to diagnose sepsis. Biosensors are devices that produce a signal proportional to analyses concentrations in biological samples. Biosensors are made up of a variety of components, including analyses, bio receptors, signal transducers, and display panels. Biosensors can identify low signals in a range of biological fluids using a minimal number of samples. Nanotechnology-based biosensors offer a revolutionary diagnostic technique that improves biomarker sensitivity and processing speed without requiring professional abilities. Biomarkers are frequently used in sepsis management for diagnostic, monitoring, prognostic, surrogate, and stratification purposes. PCT, CRP, and Interleukin-6 are three biomarkers that have proven useful in the clinical diagnosis of sepsis.

There is a significant prevalence of sepsis in Africa. According to the African Sepsis Alliance, in Africa, at least 2 million people die from sepsis each year. In addition, these figures, however, are likely to be grossly underestimated, because sepsis is rarely identified, recognized, or recorded as a cause of death in Africa. Sepsis is the third leading cause of maternal death, contributing to 11% of all maternal fatalities. Africa is predicted to have a greater incidence of maternal deaths due to sepsis, which accounts for two-thirds of infant deaths. Moreover, sepsis is a major public health issue that affects people in this region.

In well-resourced healthcare systems, there is substantial research into techniques to improve survival. Furthermore, since its beginning, the Enduring Sepsis Campaign has succeeded in elevating the profile of sepsis by raising awareness and offering evidence-based recommendations for optimal management, education, and performance improvement.

The Brazil market dominated the LAMEA Sepsis Diagnostics Market by Country in 2021, and would continue to be a dominant market till 2018; thereby, achieving a market value of $20.7 million by 2028. The Argentina market is anticipated to grow at a CAGR of 14.6% during (2022 - 2028). Additionally, The UAE market would experience a CAGR of 13.7% during (2022 - 2028).

Based on Method, the market is segmented into Conventional and Automated. Based on Test Type, the market is segmented into Laboratory Tests and Point-of-Care Tests. Based on Pathogen, the market is segmented into Bacterial Sepsis, Fungal Sepsis, Viral Sepsis, and Others. Based on Product, the market is segmented into Blood Culture Media, Assays & Reagents, Instruments, and Software. Based on End-User, the market is segmented into Hospitals & specialty clinics, Pathology & Reference Laboratories, and Research Laboratories & Academic Institutes. Based on Technology, the market is segmented into Blood Culture, Immunoassays, Molecular Diagnostics, Flow Cytometry, Microfluidics, and Biomarkers. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include BioMérieux S.A., F. Hoffmann-La Roche Ltd., Becton, Dickinson and Company, Abbott Laboratories, Thermo Fisher Scientific, Inc., DiaSorin S.p.A., Bruker Corporation, Siemens Healthineers AG, Danaher Corporation, and Quidel Corporation.

Free Valuable Insights: The Global Sepsis Diagnostics MarketMarket is Predict to reach $879.5 Million by 2028, at a CAGR of 8.3%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include BioMérieux S.A., F. Hoffmann-La Roche Ltd., Becton, Dickinson and Company, Abbott Laboratories, Thermo Fisher Scientific, Inc., DiaSorin S.p.A., Bruker Corporation, Siemens Healthineers AG, Danaher Corporation, and Quidel Corporation.

Scope of the Study

Market Segments Covered in the Report:

By Method

  • Conventional
  • Automated

By Test Type

  • Laboratory Tests
  • Point-of-Care Tests

By Pathogen

  • Bacterial Sepsis
  • Fungal Sepsis
  • Viral Sepsis
  • Others

By Product

  • Blood Culture Media
  • Assays & Reagents
  • Instruments
  • Software

By End-User

  • Hospitals & specialty clinics
  • Pathology & Reference Laboratories
  • Research Laboratories & Academic Institutes

By Technology

  • Blood Culture
  • Immunoassays
  • Molecular Diagnostics
  • Flow Cytometry
  • Microfluidics
  • Biomarkers

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

  • BioMérieux S.A.
  • F. Hoffmann-La Roche Ltd.
  • Becton, Dickinson and Company
  • Abbott Laboratories
  • Thermo Fisher Scientific, Inc.
  • DiaSorin S.p.A.
  • Bruker Corporation
  • Siemens Healthineers AG
  • Danaher Corporation
  • Quidel Corporation

Unique Offerings from KBV Research

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Related Reports:

Global Sepsis Diagnostics MarketMarket Report 2022-2028

North America Sepsis Diagnostics MarketMarket Report 2022-2028

Asia Pacific Sepsis Diagnostics MarketMarket Report 2022-2028

LAMEA Sepsis Diagnostics MarketMarket Report 2022-2028

Purchase Report

 1500
 1800
 2520

Special Pricing & Discounts

  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities